StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Zivo Bioscience's operating income for the twelve months ending Sep 30, 2025 was -$8.46M. For fiscal 2024 it was -$13.36M. The highest annual figure on record is -$1.94M in fiscal 2011.

Annual operating income

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$13.36M–
FY2023Dec 31, 2023-$7.26M–
FY2022Dec 31, 2022-$8.73M–
FY2021Dec 31, 2021-$8.65M–
FY2020Dec 31, 2020-$8.56M–
FY2019Dec 31, 2019-$8.35M–
FY2018Dec 31, 2018-$6.13M–
FY2017Dec 31, 2017-$6.33M–
FY2016Dec 31, 2016-$3.49M–
FY2015Dec 31, 2015-$3.06M–
FY2014Dec 31, 2014-$5.15M–
FY2013Dec 31, 2013-$3.11M–
FY2012Dec 31, 2012-$2.08M–
FY2011Dec 31, 2011-$1.94M–
FY2010Dec 31, 2010-$4.06M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$1.02M–
Q2 FY2025Jun 30, 2025-$1.63M–
Q1 FY2025Mar 31, 2025-$4.21M–
Q4 FY2024Dec 31, 2024-$1.60M–
Q3 FY2024Sep 30, 2024-$2.26M–
Q2 FY2024Jun 30, 2024-$8.23M–
Q1 FY2024Mar 31, 2024-$1.28M–
Q4 FY2023Dec 31, 2023-$1.90M–
Q3 FY2023Sep 30, 2023-$1.57M–
Q2 FY2023Jun 30, 2023-$1.82M–
Q1 FY2023Mar 31, 2023-$1.97M–
Q4 FY2022Dec 31, 2022-$2.64M–
Q3 FY2022Sep 30, 2022-$2.00M–
Q2 FY2022Jun 30, 2022-$2.07M–
Q1 FY2022Mar 31, 2022-$2.03M–
Q4 FY2021Dec 31, 2021-$3.26M–
Q3 FY2021Sep 30, 2021-$1.67M–
Q2 FY2021Jun 30, 2021-$1.75M–
Q1 FY2021Mar 31, 2021-$2.08M–
Q4 FY2020Dec 31, 2020-$1.76M–
Q3 FY2020Sep 30, 2020-$3.36M–
Q2 FY2020Jun 30, 2020-$1.03M–
Q1 FY2020Mar 31, 2020-$2.41M–
Q4 FY2019Dec 31, 2019-$3.77M–
Q3 FY2019Sep 30, 2019-$1.57M–
Q2 FY2019Jun 30, 2019-$2.04M–
Q1 FY2019Mar 31, 2019-$967.85K–
Q4 FY2018Dec 31, 2018-$1.62M–
Q3 FY2018Sep 30, 2018-$1.49M–
Q2 FY2018Jun 30, 2018-$1.34M–
Q1 FY2018Mar 31, 2018-$1.68M–
Q4 FY2017Dec 31, 2017-$2.60M–
Q3 FY2017Sep 30, 2017-$2.06M–
Q2 FY2017Jun 30, 2017-$881.45K–
Q1 FY2017Mar 31, 2017-$791.27K–
Q4 FY2016Dec 31, 2016-$642.66K–
Q3 FY2016Sep 30, 2016-$677.12K–
Q2 FY2016Jun 30, 2016-$1.53M–
Q1 FY2016Mar 31, 2016-$640.56K–
Q4 FY2015Dec 31, 2015-$663.75K–

More Zivo Bioscience figures

See a number that looks wrong?